View Item 

Show simple item record

Hepatic encephalopathy impacts the predictive value of the Fried Frailty Index
dc.contributor.authorTapper, Elliot B.
dc.contributor.authorKonerman, Monica
dc.contributor.authorMurphy, Susan
dc.contributor.authorSonnenday, Christopher J.
dc.date.accessioned2018-11-20T15:32:49Z
dc.date.available2019-12-02T14:55:09Zen
dc.date.issued2018-10
dc.identifier.citationTapper, Elliot B.; Konerman, Monica; Murphy, Susan; Sonnenday, Christopher J. (2018). "Hepatic encephalopathy impacts the predictive value of the Fried Frailty Index." American Journal of Transplantation 18(10): 2566-2570.
dc.identifier.issn1600-6135
dc.identifier.issn1600-6143
dc.identifier.urihttps://hdl.handle.net/2027.42/146338
dc.publisherWiley Periodicals, Inc.
dc.subject.otherpatient survival
dc.subject.othercirrhosis
dc.subject.otherclinical research/practice
dc.subject.otherhealth services and outcomes research
dc.subject.otherliver transplantation/hepatology
dc.titleHepatic encephalopathy impacts the predictive value of the Fried Frailty Index
dc.typeArticleen_US
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelMedicine (General)
dc.subject.hlbtoplevelHealth Sciences
dc.description.peerreviewedPeer Reviewed
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/146338/1/ajt15020.pdf
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/146338/2/ajt15020_am.pdf
dc.identifier.doi10.1111/ajt.15020
dc.identifier.sourceAmerican Journal of Transplantation
dc.identifier.citedreferencePatidar KR, Thacker LR, Wade JB, et al. Covert hepatic encephalopathy is independently associated with poor survival and increased risk of hospitalization. Am J Gastroenterol. 2014; 109: 1757.
dc.identifier.citedreferenceTapper EB, Finkelstein D, Mittleman MA, Piatkowski G, Lai M. Standard assessments of frailty are validated predictors of mortality in hospitalized patients with cirrhosis. Hepatology. 2015; 62: 584 ‐ 590.
dc.identifier.citedreferenceOrman ES, Ghabril M, Chalasani N. Poor performance status is associated with increased mortality in patients with cirrhosis. Clin Gastroenterol Hepatol. 2016; 14 ( 1189–95 ): e1.
dc.identifier.citedreferenceTapper EB, Su GL. Karnofsky performance status for transplant‐waitlisted patients with cirrhosis: does it meet the eye‐ball test? Clin Gastroenterol Hepatol. 2016; 14; 1196 ‐ 1198
dc.identifier.citedreferenceLai JC, Covinsky KE, Dodge JL, et al. Development of a novel frailty index to predict mortality in patients with end‐stage liver disease. Hepatology. 2017; 66: 564 ‐ 574.
dc.identifier.citedreferenceDunn MA, Josbeno DA, Tevar AD, et al. Frailty as tested by gait speed is an independent risk factor for cirrhosis complications that require hospitalization. Am J Gastroenterol. 2016; 111: 1768.
dc.identifier.citedreferenceEnglesbe MJ, Lee JS, He K, et al. Analytic morphomics, core muscle size, and surgical outcomes. Ann Surg. 2012; 256: 255 ‐ 261.
dc.identifier.citedreferenceEnglesbe MJ, Patel SP, He K, et al. Sarcopenia and mortality after liver transplantation. J Am Coll Surg. 2010; 211: 271 ‐ 278.
dc.identifier.citedreferenceFried LP, Tangen CM, Walston J, et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001; 56: M146 – M157.
dc.identifier.citedreferenceTapper EB, Jiang ZG, Patwardhan VR. Refining the ammonia hypothesis: a physiology‐driven approach to the treatment of hepatic encephalopathy. Mayo Clin Proc. 2015; 90: 646 ‐ 658.
dc.identifier.citedreferenceKumar A, Davuluri G, Engelen MP, et al. Ammonia lowering reverses sarcopenia of cirrhosis by restoring skeletal muscle proteostasis. Hepatology. 2017; 65: 2045 ‐ 2058.
dc.identifier.citedreferenceNabi E, Thacker LR, Wade JB, et al. Diagnosis of covert hepatic encephalopathy without specialized tests. Clin Gastroenterol Hepatol. 2014; 12 ( 1384–9 ): e2.
dc.identifier.citedreferenceCron D, Friedman J, Winder G, et al. Depression and frailty in patients with end‐stage liver disease referred for transplant evaluation. Am J Transplant. 2016; 16: 1805 ‐ 1811.
dc.identifier.citedreferenceEzaz G, Murphy SL, Mellinger J, Tapper EB. Increased morbidity and mortality associated with falls among patients with cirrhosis. Am J Med. 2018; 131: 645 ‐ 650.e2.
dc.identifier.citedreferenceTandon P, Tangri N, Thomas L, et al. A rapid bedside screen to predict unplanned hospitalization and death in outpatients with cirrhosis: a prospective evaluation of the clinical frailty scale. Am J Gastroenterol. 2016; 111: 1759 ‐ 1767.
dc.identifier.citedreferencePrasad S, Dhiman RK, Duseja A, Chawla YK, Sharma A, Agarwal R. Lactulose improves cognitive functions and health‐related quality of life in patients with cirrhosis who have minimal hepatic encephalopathy. Hepatology. 2007; 45: 549 ‐ 559.
dc.identifier.citedreferenceBajaj JS, Heuman DM, Wade JB, et al. Rifaximin improves driving simulator performance in a randomized trial of patients with minimal hepatic encephalopathy. Gastroenterology. 2011; 140 ( 478–87 ): e1.
dc.identifier.citedreferenceVilstrup H, Amodio P, Bajaj J, et al. Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver. Hepatology. 2014; 60: 715 ‐ 735.
dc.identifier.citedreferenceTapper EB, Parikh ND, Waljee AK, Volk M, Carlozzi NE, Lok AS. Diagnosis of minimal hepatic encephalopathy: a systematic review of point‐of‐care diagnostic tests. Am J Gastroenterol. 2018; 113: 529 ‐ 538
dc.identifier.citedreferenceBajaj JS, Heuman DM, Sterling RK, et al. Validation of EncephalApp, smartphone‐based stroop test, for the diagnosis of covert hepatic encephalopathy. Clin Gastroenterol Hepatol. 2015; 13 ( 1828–35 ): e1.
dc.identifier.citedreferenceSinclair M, Poltavskiy E, Dodge JL, Lai JC. Frailty is independently associated with increased hospitalisation days in patients on the liver transplant waitlist. World J Gastroenterol. 2017; 23: 899.
dc.identifier.citedreferencePatel AV, Wade JB, Thacker LR, et al. Cognitive reserve is a determinant of health‐related quality of life in patients with cirrhosis, independent of covert hepatic encephalopathy and model for end‐stage liver disease score. Clin Gastroenterol Hepatol. 2015; 13: 987 ‐ 991.
dc.identifier.citedreferenceLai JC, Covinsky KE, Hayssen H, et al. Clinician assessments of health status predict mortality in patients with end‐stage liver disease awaiting liver transplantation. Liver Int. 2015; 35: 2167 ‐ 2173.
dc.identifier.citedreferenceLai JC, Dodge JL, Sen S, Covinsky K, Feng S. Functional decline in patients with cirrhosis awaiting liver transplantation: results from the functional assessment in liver transplantation (FrAILT) study. Hepatology. 2016; 63: 574 ‐ 580.
dc.identifier.citedreferenceLai JC, Feng S, Terrault N, Lizaola B, Hayssen H, Covinsky K. Frailty predicts waitlist mortality in liver transplant candidates. Am J Transplant. 2014; 14: 1870 ‐ 1879.
dc.identifier.citedreferenceTandon P, Ney M, Irwin I, et al. Severe muscle depletion in patients on the liver transplant wait list: its prevalence and independent prognostic value. LiverTranspl. 2012; 18: 1209 ‐ 1216.
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
ajt15020.pdf
Size:
300.5KB
Format:
PDF
View/Open
Name:
ajt15020_am.pdf
Size:
148.2KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.